ResearcherOregon Health & Science UniversityActive in the last 2 years
Robert L Eil
Matched on ORCID iD 0000-0003-3030-9327; OpenAlex author ID A5042431372. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 2)
- Trials
- 0
- Grants
- 1
- Labs led
- 1
- Collaborators
- 24
2021: 1 grant · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 3 papers
Papers 5
- Interleukin 6 Drives Durable T Cell-Mediated Immunity to Pancreatic Cancer. Co-author DOI 10.1016/j.jcmgh.2026.101768↗
- The Posttranscriptional Regulator HuR Promotes Immune Evasion in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1136/jitc-2025-sitc2025.1250↗
- Increased Glucose Availability Sensitizes Pancreatic Cancer to Macrophage-Targeting Immunotherapies. Co-author DOI 10.1158/2767-9764.crc-25-0338↗
- Post-transcriptional regulator HuR promotes immune evasion in pancreatic ductal adenocarcinoma Last author DOI 10.1101/2025.02.07.632847↗
- Hepatic signal transducer and activator of transcription-3 signalling drives early-stage pancreatic cancer cachexia via suppressed ketogenesis. Co-author DOI 10.1002/jcsm.13466↗
Grants 1
Closest collaborators
The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Aaron J. Grossberg · 4 shared papers, 2024–2026 · strength 0.89
- Paper Interleukin 6 Drives Durable T Cell-Mediated Immunity to Pancreatic Cancer. DOI 10.1016/j.jcmgh.2026.101768↗
- Paper The Posttranscriptional Regulator HuR Promotes Immune Evasion in Pancreatic Ductal Adenocarcinoma. DOI 10.1136/jitc-2025-sitc2025.1250↗
- Paper Hepatic signal transducer and activator of transcription-3 signalling drives early-stage pancreatic cancer cachexia via… DOI 10.1002/jcsm.13466↗
- Lisa M. Coussens · 3 shared papers, 2025–2026 · strength 0.66
- Paper Increased Glucose Availability Sensitizes Pancreatic Cancer to Macrophage-Targeting Immunotherapies. DOI 10.1158/2767-9764.crc-25-0338↗
- Paper The Posttranscriptional Regulator HuR Promotes Immune Evasion in Pancreatic Ductal Adenocarcinoma. DOI 10.1136/jitc-2025-sitc2025.1250↗
- Paper Post-transcriptional regulator HuR promotes immune evasion in pancreatic ductal adenocarcinoma DOI 10.1101/2025.02.07.632847↗
- Katie E. Blise · 3 shared papers, 2025–2026 · strength 0.66
- Paper Increased Glucose Availability Sensitizes Pancreatic Cancer to Macrophage-Targeting Immunotherapies. DOI 10.1158/2767-9764.crc-25-0338↗
- Paper The Posttranscriptional Regulator HuR Promotes Immune Evasion in Pancreatic Ductal Adenocarcinoma. DOI 10.1136/jitc-2025-sitc2025.1250↗
- Paper Post-transcriptional regulator HuR promotes immune evasion in pancreatic ductal adenocarcinoma DOI 10.1101/2025.02.07.632847↗
- Rosalie C. Sears · 3 shared papers, 2025–2026 · strength 0.66
- Paper Increased Glucose Availability Sensitizes Pancreatic Cancer to Macrophage-Targeting Immunotherapies. DOI 10.1158/2767-9764.crc-25-0338↗
- Paper The Posttranscriptional Regulator HuR Promotes Immune Evasion in Pancreatic Ductal Adenocarcinoma. DOI 10.1136/jitc-2025-sitc2025.1250↗
- Paper Post-transcriptional regulator HuR promotes immune evasion in pancreatic ductal adenocarcinoma DOI 10.1101/2025.02.07.632847↗
- Jonathan Robert Brody · 3 shared papers, 2025–2026 · strength 0.66
- Paper Increased Glucose Availability Sensitizes Pancreatic Cancer to Macrophage-Targeting Immunotherapies. DOI 10.1158/2767-9764.crc-25-0338↗
- Paper The Posttranscriptional Regulator HuR Promotes Immune Evasion in Pancreatic Ductal Adenocarcinoma. DOI 10.1136/jitc-2025-sitc2025.1250↗
- Paper Post-transcriptional regulator HuR promotes immune evasion in pancreatic ductal adenocarcinoma DOI 10.1101/2025.02.07.632847↗
- Paige C. Arneson‐Wissink · 2 shared papers, 2024–2026 · strength 0.46
- Katherine R. Pelz · 2 shared papers, 2024–2026 · strength 0.44
- Jennifer M. Finan · 2 shared papers, 2025–2026 · strength 0.43
- Yifei Guo · 2 shared papers, 2025–2026 · strength 0.43
- Kevin Hawthorne · 2 shared papers, 2025–2026 · strength 0.43
- Grace A. McCarthy · 2 shared papers, 2025–2026 · strength 0.43
- Zheng Xia · 2 shared papers, 2025–2026 · strength 0.43
- Canping Chen · 2 shared papers, 2025–2026 · strength 0.43
- Parham Diba · 1 shared paper, 2026 · strength 0.24
- Katelyn T. Byrne · 1 shared paper, 2026 · strength 0.24
- Jonathan J. Hue · 1 shared paper, 2026 · strength 0.23
- Erryk Katayama · 1 shared paper, 2026 · strength 0.23
- Ali Vaziri Gohar · 1 shared paper, 2026 · strength 0.23
- Sami O. Abul-Khoudoud · 1 shared paper, 2026 · strength 0.23
- Mehrdad Zarei · 1 shared paper, 2026 · strength 0.23
- Omid Hajihassani · 1 shared paper, 2026 · strength 0.23
- Jordan Michael Winter · 1 shared paper, 2026 · strength 0.23
- Charles D. Lopez · 1 shared paper, 2026 · strength 0.23
- Vidhi M. Shah · 1 shared paper, 2026 · strength 0.22
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.